Last week, Beta Bionics, Inc. (NASDAQ:BBNX) insiders, who had purchased shares in the previous 12 months were rewarded handsomely. The shares increased by 23% last week, resulting in a US$186m ...

The recent price decline of 62% in Argenica Therapeutics Limited's ( ASX:AGN ) stock may have disappointed insiders ...